Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Protagonist Therapeutics, Inc (PTGX)  
$29.61 0.29 (0.99%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 57,680,000
Market Cap: 1.71(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.05 - $32.15
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Protagonist Therapeutics is a clinical-stage biopharmaceutical company with various peptide-based new chemical entities in different stages of development, all derived from Co.'s proprietary technology platform. Co.'s clinical programs address two main categories of diseases; hematology and blood disorders, and inflammatory and immunomodulatory diseases. Co.'s main clinical asset, rusfertide (generic name for PTG-300) is an injectable hepcidin mimetic in development for the potential treatment of erythrocytosis, iron overload and other blood disorders. PN-943 is an investigational, orally delivered, gut-restricted alpha-4-beta-7 specific integrin antagonist for inflammatory bowel disease.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 93,396 175,244 175,244 175,244
Total Sell Value $2,858,339 $4,519,351 $4,519,351 $4,519,351
Total People Sold 3 5 5 5
Total Sell Transactions 6 9 9 9
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 166
  Page 5 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Canaan Partners X Llc 10% Owner   –       –       •   2018-05-16 4 S $6.46 $190,071 D/D (29,441) 2,155,520     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-05-15 4 S $6.48 $374,080 D/D (57,715) 2,184,961     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-05-14 4 S $6.37 $494,224 D/D (77,591) 2,242,676     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2018-05-10 4 OE $1.16 $15,679 D/D 13,516 265,779     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2018-04-02 4 OE $1.16 $23,200 D/D 20,000 252,263     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2018-03-26 4 OE $0.87 $9,829 D/D 11,298 232,263     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-23 4 S $20.71 $1,241,325 D/D (59,950) 2,320,267     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-22 4 S $20.62 $98,133 D/D (4,759) 2,380,217     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-21 4 S $20.61 $364,727 D/D (17,699) 2,384,976     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-20 4 S $20.61 $351,538 D/D (17,060) 2,402,675     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-19 4 S $20.57 $276,446 D/D (13,439) 2,419,735     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-16 4 S $20.51 $142,063 D/D (6,926) 2,433,174     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-15 4 S $20.64 $242,521 D/D (11,751) 2,440,100     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-14 4 S $20.77 $4,154 D/D (200) 2,451,851     -
   Canaan Partners X Llc 10% Owner   –       –       •   2018-03-13 4 S $20.84 $25,094 D/D (1,204) 2,452,051     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-03-12 4 AS $21.29 $74,500 D/D (3,500) 15,028     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-03-12 4 OE $4.21 $14,735 D/D 3,500 18,528     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-03-02 4 AS $20.00 $17,500 D/D (875) 13,322     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-03-02 4 OE $1.89 $1,654 D/D 875 14,197     -
   Patel Dinesh V Ph D President and CEO   •       •      –    2018-02-28 4 A $0.00 $0 D/D 25,000 219,259     -
   Oneil Thomas P. Chief Financial Officer   •       –      –    2018-02-28 4 A $0.00 $0 D/D 6,000 8,858     -
   Shame Richard S Chief Medical Officer   •       –      –    2018-02-28 4 A $0.00 $0 D/D 6,500 6,500     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-02-28 4 A $0.00 $0 D/D 9,500 13,322     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-01-16 4 AS $20.00 $17,500 D/D (875) 3,822     -
   Liu David Y Chief Scientific Officer   •       –      –    2018-01-16 4 OE $1.89 $1,654 D/D 875 4,697     -
  166 Records found
  1  2  3  4  5  6  7   
  Page 5 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us